JPWO2021041885A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021041885A5 JPWO2021041885A5 JP2022513443A JP2022513443A JPWO2021041885A5 JP WO2021041885 A5 JPWO2021041885 A5 JP WO2021041885A5 JP 2022513443 A JP2022513443 A JP 2022513443A JP 2022513443 A JP2022513443 A JP 2022513443A JP WO2021041885 A5 JPWO2021041885 A5 JP WO2021041885A5
- Authority
- JP
- Japan
- Prior art keywords
- tada
- spcas9
- deaminase
- sequence
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962893638P | 2019-08-29 | 2019-08-29 | |
| US62/893,638 | 2019-08-29 | ||
| PCT/US2020/048510 WO2021041885A2 (en) | 2019-08-29 | 2020-08-28 | Compositions and methods for editing a mutation to permit transcription or expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545950A JP2022545950A (ja) | 2022-11-01 |
| JPWO2021041885A5 true JPWO2021041885A5 (de) | 2023-09-05 |
Family
ID=74684607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513443A Pending JP2022545950A (ja) | 2019-08-29 | 2020-08-28 | 転写または発現を可能にするように変異を編集するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220313799A1 (de) |
| EP (1) | EP4022050A2 (de) |
| JP (1) | JP2022545950A (de) |
| KR (1) | KR20220066289A (de) |
| CN (1) | CN114641567A (de) |
| AU (1) | AU2020336953A1 (de) |
| CA (1) | CA3152861A1 (de) |
| WO (1) | WO2021041885A2 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021222318A1 (en) | 2020-04-28 | 2021-11-04 | The Broad Institute, Inc. | Targeted base editing of the ush2a gene |
| CN115348870B (zh) * | 2021-03-16 | 2023-06-13 | 上海驯鹿生物技术有限公司 | 通用型嵌合抗原受体t细胞及其应用 |
| WO2023102550A2 (en) | 2021-12-03 | 2023-06-08 | The Broad Institute, Inc. | Compositions and methods for efficient in vivo delivery |
| KR20230166378A (ko) | 2022-05-30 | 2023-12-07 | 현대자동차주식회사 | 차량의 제동 방법 및 장치 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2502636C (en) * | 2002-08-30 | 2013-11-19 | The Hospital For Sick Children | Diagnosis of shwachman-diamond syndrome |
| US20110151447A1 (en) * | 2007-11-06 | 2011-06-23 | Children's Medical Center Corporation | Method to produce induced pluripotent stem (ips) cells from non-embryonic human cells |
| IL258821B (en) * | 2015-10-23 | 2022-07-01 | Harvard College | Nucleobase editors and their uses |
| KR20200006054A (ko) * | 2017-04-12 | 2020-01-17 | 더 브로드 인스티튜트, 인코퍼레이티드 | 신규 타입 vi crispr 오르소로그 및 시스템 |
| CN109306361B (zh) * | 2018-02-11 | 2022-06-28 | 华东师范大学 | 一种新的a/t到g/c碱基定点转换的基因编辑系统 |
-
2020
- 2020-08-28 CA CA3152861A patent/CA3152861A1/en active Pending
- 2020-08-28 US US17/638,757 patent/US20220313799A1/en active Pending
- 2020-08-28 EP EP20856306.4A patent/EP4022050A2/de active Pending
- 2020-08-28 CN CN202080076243.7A patent/CN114641567A/zh active Pending
- 2020-08-28 WO PCT/US2020/048510 patent/WO2021041885A2/en unknown
- 2020-08-28 JP JP2022513443A patent/JP2022545950A/ja active Pending
- 2020-08-28 AU AU2020336953A patent/AU2020336953A1/en active Pending
- 2020-08-28 KR KR1020227010126A patent/KR20220066289A/ko unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210002665A1 (en) | Rna-guided gene editing and gene regulation | |
| JP7197363B2 (ja) | ヌクレアーゼを使用するヒト神経幹細胞のゲノム編集 | |
| US20200155606A1 (en) | Crispr/rna-guided nuclease systems and methods | |
| JP6170080B2 (ja) | 異常ヘモグロビン症の治療のための組成物および方法 | |
| US11752202B2 (en) | Compositions and methods for treating hemoglobinopathies | |
| AU2017235333A1 (en) | CRISPR/CAS-related methods and compositions for treating beta hemoglobinopathies | |
| AU2020336969A1 (en) | Compositions and methods for non-toxic conditioning | |
| CN110551761A (zh) | CRISPR/Sa-SepCas9基因编辑系统及其应用 | |
| Li et al. | Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research | |
| JPWO2021050571A5 (de) | ||
| JP2022526429A (ja) | Ａｍｄの処置のためのｈｔｒａ１調節 | |
| CN110577971A (zh) | CRISPR/Sa-SauriCas9基因编辑系统及其应用 | |
| JPWO2021041885A5 (de) | ||
| Jo et al. | In vivo application of base and prime editing to treat inherited retinal diseases | |
| JP2020517289A5 (de) | ||
| CN110551763B (zh) | CRISPR/SlutCas9基因编辑系统及其应用 | |
| CN115851706A (zh) | 一种碱基编辑系统及其应用 | |
| CA3001594A1 (en) | Nucleic acid molecules containing spacers and methods of use thereof | |
| CN110551760A (zh) | 一种CRISPR/Sa-SeqCas9基因编辑系统和其应用 | |
| CN110577970A (zh) | CRISPR/Sa-SlutCas9基因编辑系统及其应用 | |
| US20230248810A1 (en) | Method for treating alzheimer's disease by targeting mapt gene | |
| US20240122989A1 (en) | Methods and compositions for production of genetically modified primary cells | |
| KR20220106079A (ko) | Francisella novicida Cas9 모듈 기반의 역전사 효소를 사용한 유전체 치환 및 삽입 기술 | |
| KR20230120366A (ko) | CRISPR-Cas12a 기반의 닉카아제를 포함하는 유전체 편집용 조성물 | |
| CN115873850A (zh) | 腺嘌呤碱基编辑系统及其应用 |